BiliTool™

Patient Summary
Age at sampling:		12 hours
Total Bilirubin:		210.4 µmol/L
Bilirubin trend:		Not available (learn more)
Gestational Age (GA):		39 weeks
Neurotoxicity Risk Factors:		No

~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
Hyperbilirubinemia management summary (1,2) for a newborn at 39 weeks gestation with a total bilirubin of 210.4 µmol/L collected at 12 hours of age with no known neurotoxicity risk factors.

Treatment thresholds:
The baby is *at or above* the threshold for reflex testing with total serum bilirubin (TSB) if using transcutaneous bilirubin (TcB) (131.67 µmol/L); *above* the phototherapy threshold (181.3 µmol/L); *below* the escalation of care threshold (303.3 µmol/L) and *below* the exchange transfusion threshold (337.5 µmol/L).

Postdischarge Follow Up:
 Because phototherapy is recommended, there are no postdischarge recommendations at this time.

1. Recommendations derived from 'Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation' [Pediatrics. 2022 Sep 1;150(3)] by the American Academy of Pediatrics (AAP).
2. Generated by BiliTool (https://bilitool.org) 2024 Apr 28 05:50:22 UTC. BiliTool serves only as a reference aid. It is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~

Recommendations
	Recommendation	Threshold
If using TcB, confirm with TSB?	Yes	131.67 µmol/L
Phototherapy?	Yes	181.3 µmol/L
Escalation of Care? (learn more)	No	303.3 µmol/L
Exchange Transfusion?	No	337.5 µmol/L

Postdischarge Follow Up
Because phototherapy is recommended, there are no postdischarge recommendations at this time.